CORD-19:932bcdd2f6c6d487386e8bf983e4874387771be1 / 452918-453360 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T1251","span":{"begin":0,"end":442},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"We have screened serum from 107 patients with relapsing-remitting MS (RRMS) against a library of glycans on a glycan chip, and have found significantly higher levels of IgM anti-Glc(alpha 1,4)Glc(alpha) antibodies (anti-Ga4Ga antibodies) than in 77 control patients suffering from other neurological diseases ( pb0.001) and other autoimmune diseases ( p=0.03), and higher levels than in 20 patients with primary progressive MS (PPMS, p=0.06)."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T198","span":{"begin":0,"end":442},"obj":"Sentence"}],"text":"We have screened serum from 107 patients with relapsing-remitting MS (RRMS) against a library of glycans on a glycan chip, and have found significantly higher levels of IgM anti-Glc(alpha 1,4)Glc(alpha) antibodies (anti-Ga4Ga antibodies) than in 77 control patients suffering from other neurological diseases ( pb0.001) and other autoimmune diseases ( p=0.03), and higher levels than in 20 patients with primary progressive MS (PPMS, p=0.06)."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T921","span":{"begin":330,"end":349},"obj":"Phenotype"}],"attributes":[{"id":"A921","pred":"hp_id","subj":"T921","obj":"http://purl.obolibrary.org/obo/HP_0002960"}],"text":"We have screened serum from 107 patients with relapsing-remitting MS (RRMS) against a library of glycans on a glycan chip, and have found significantly higher levels of IgM anti-Glc(alpha 1,4)Glc(alpha) antibodies (anti-Ga4Ga antibodies) than in 77 control patients suffering from other neurological diseases ( pb0.001) and other autoimmune diseases ( p=0.03), and higher levels than in 20 patients with primary progressive MS (PPMS, p=0.06)."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T1496","span":{"begin":17,"end":22},"obj":"Body_part"}],"attributes":[{"id":"A1496","pred":"uberon_id","subj":"T1496","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"}],"text":"We have screened serum from 107 patients with relapsing-remitting MS (RRMS) against a library of glycans on a glycan chip, and have found significantly higher levels of IgM anti-Glc(alpha 1,4)Glc(alpha) antibodies (anti-Ga4Ga antibodies) than in 77 control patients suffering from other neurological diseases ( pb0.001) and other autoimmune diseases ( p=0.03), and higher levels than in 20 patients with primary progressive MS (PPMS, p=0.06)."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T3089","span":{"begin":46,"end":68},"obj":"Disease"},{"id":"T3090","span":{"begin":66,"end":68},"obj":"Disease"},{"id":"T3091","span":{"begin":70,"end":74},"obj":"Disease"},{"id":"T3092","span":{"begin":287,"end":308},"obj":"Disease"},{"id":"T3093","span":{"begin":330,"end":349},"obj":"Disease"},{"id":"T3094","span":{"begin":404,"end":426},"obj":"Disease"},{"id":"T3095","span":{"begin":424,"end":426},"obj":"Disease"},{"id":"T3096","span":{"begin":428,"end":432},"obj":"Disease"},{"id":"T65934","span":{"begin":46,"end":68},"obj":"Disease"},{"id":"T39036","span":{"begin":66,"end":68},"obj":"Disease"},{"id":"T97672","span":{"begin":70,"end":74},"obj":"Disease"},{"id":"T73277","span":{"begin":287,"end":308},"obj":"Disease"},{"id":"T19318","span":{"begin":330,"end":349},"obj":"Disease"},{"id":"T13707","span":{"begin":404,"end":426},"obj":"Disease"},{"id":"T37418","span":{"begin":424,"end":426},"obj":"Disease"},{"id":"T84556","span":{"begin":428,"end":432},"obj":"Disease"}],"attributes":[{"id":"A3089","pred":"mondo_id","subj":"T3089","obj":"http://purl.obolibrary.org/obo/MONDO_0005314"},{"id":"A3090","pred":"mondo_id","subj":"T3090","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A3091","pred":"mondo_id","subj":"T3091","obj":"http://purl.obolibrary.org/obo/MONDO_0005314"},{"id":"A3092","pred":"mondo_id","subj":"T3092","obj":"http://purl.obolibrary.org/obo/MONDO_0005071"},{"id":"A3093","pred":"mondo_id","subj":"T3093","obj":"http://purl.obolibrary.org/obo/MONDO_0007179"},{"id":"A3094","pred":"mondo_id","subj":"T3094","obj":"http://purl.obolibrary.org/obo/MONDO_0000451"},{"id":"A3095","pred":"mondo_id","subj":"T3095","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A3096","pred":"mondo_id","subj":"T3096","obj":"http://purl.obolibrary.org/obo/MONDO_0000451"},{"id":"A30734","pred":"mondo_id","subj":"T65934","obj":"http://purl.obolibrary.org/obo/MONDO_0005314"},{"id":"A35648","pred":"mondo_id","subj":"T39036","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A86408","pred":"mondo_id","subj":"T97672","obj":"http://purl.obolibrary.org/obo/MONDO_0005314"},{"id":"A39102","pred":"mondo_id","subj":"T73277","obj":"http://purl.obolibrary.org/obo/MONDO_0005071"},{"id":"A81525","pred":"mondo_id","subj":"T19318","obj":"http://purl.obolibrary.org/obo/MONDO_0007179"},{"id":"A15150","pred":"mondo_id","subj":"T13707","obj":"http://purl.obolibrary.org/obo/MONDO_0000451"},{"id":"A46484","pred":"mondo_id","subj":"T37418","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A15945","pred":"mondo_id","subj":"T84556","obj":"http://purl.obolibrary.org/obo/MONDO_0000451"}],"text":"We have screened serum from 107 patients with relapsing-remitting MS (RRMS) against a library of glycans on a glycan chip, and have found significantly higher levels of IgM anti-Glc(alpha 1,4)Glc(alpha) antibodies (anti-Ga4Ga antibodies) than in 77 control patients suffering from other neurological diseases ( pb0.001) and other autoimmune diseases ( p=0.03), and higher levels than in 20 patients with primary progressive MS (PPMS, p=0.06)."}